Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics:
In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Dordrecht
Springer Netherlands
2012
|
| Ausgabe: | 1st ed. 2012 |
| Schriftenreihe: | Cancer Growth and Progression
14 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies. |
| Beschreibung: | 1 Online-Ressource (VI, 426 Seiten) |
| ISBN: | 9789400750289 |
| DOI: | 10.1007/978-94-007-5028-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV047942890 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220414s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 9789400750289 |9 978-94-007-5028-9 | ||
| 024 | 7 | |a 10.1007/978-94-007-5028-9 |2 doi | |
| 035 | |a (ZDB-2-SME)978-94-007-5028-9 | ||
| 035 | |a (OCoLC)1312702829 | ||
| 035 | |a (DE-599)BVBBV047942890 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 614.5999 |2 23 | |
| 245 | 1 | 0 | |a Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics |c edited by Jianguo Tao, Eduardo Sotomayor |
| 250 | |a 1st ed. 2012 | ||
| 264 | 1 | |a Dordrecht |b Springer Netherlands |c 2012 | |
| 300 | |a 1 Online-Ressource (VI, 426 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Cancer Growth and Progression |v 14 | |
| 520 | |a In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies. | ||
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Laboratory Medicine | |
| 650 | 4 | |a Molecular Medicine | |
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a Cell Biology | |
| 650 | 4 | |a Cancer research | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Laboratory medicine | |
| 650 | 4 | |a Molecular biology | |
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a Cell biology | |
| 700 | 1 | |a Tao, Jianguo |4 edt | |
| 700 | 1 | |a Sotomayor, Eduardo |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789400750296 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789400795815 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789400750272 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-007-5028-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_2012 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033324345 | ||
| 966 | e | |u https://doi.org/10.1007/978-94-007-5028-9 |l UBR01 |p ZDB-2-SME |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804183589787533312 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Tao, Jianguo Sotomayor, Eduardo |
| author2_role | edt edt |
| author2_variant | j t jt e s es |
| author_facet | Tao, Jianguo Sotomayor, Eduardo |
| building | Verbundindex |
| bvnumber | BV047942890 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-94-007-5028-9 (OCoLC)1312702829 (DE-599)BVBBV047942890 |
| dewey-full | 614.5999 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.5999 |
| dewey-search | 614.5999 |
| dewey-sort | 3614.5999 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1007/978-94-007-5028-9 |
| edition | 1st ed. 2012 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03182nmm a2200565zcb4500</leader><controlfield tag="001">BV047942890</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220414s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789400750289</subfield><subfield code="9">978-94-007-5028-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-007-5028-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-007-5028-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1312702829</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047942890</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.5999</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics</subfield><subfield code="c">edited by Jianguo Tao, Eduardo Sotomayor</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2012</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VI, 426 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cancer Growth and Progression</subfield><subfield code="v">14</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies. </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Laboratory Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Apoptosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cell Biology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Laboratory medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular biology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Apoptosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cell biology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tao, Jianguo</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sotomayor, Eduardo</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789400750296</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789400795815</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789400750272</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-007-5028-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2012</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033324345</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-007-5028-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047942890 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T19:35:40Z |
| indexdate | 2024-07-10T09:25:51Z |
| institution | BVB |
| isbn | 9789400750289 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033324345 |
| oclc_num | 1312702829 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (VI, 426 Seiten) |
| psigel | ZDB-2-SME ZDB-2-SME_2012 |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Springer Netherlands |
| record_format | marc |
| series2 | Cancer Growth and Progression |
| spelling | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics edited by Jianguo Tao, Eduardo Sotomayor 1st ed. 2012 Dordrecht Springer Netherlands 2012 1 Online-Ressource (VI, 426 Seiten) txt rdacontent c rdamedia cr rdacarrier Cancer Growth and Progression 14 In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies. Cancer Research Hematology Laboratory Medicine Molecular Medicine Apoptosis Cell Biology Cancer research Laboratory medicine Molecular biology Cell biology Tao, Jianguo edt Sotomayor, Eduardo edt Erscheint auch als Druck-Ausgabe 9789400750296 Erscheint auch als Druck-Ausgabe 9789400795815 Erscheint auch als Druck-Ausgabe 9789400750272 https://doi.org/10.1007/978-94-007-5028-9 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics Cancer Research Hematology Laboratory Medicine Molecular Medicine Apoptosis Cell Biology Cancer research Laboratory medicine Molecular biology Cell biology |
| title | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics |
| title_auth | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics |
| title_exact_search | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics |
| title_exact_search_txtP | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics |
| title_full | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics edited by Jianguo Tao, Eduardo Sotomayor |
| title_fullStr | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics edited by Jianguo Tao, Eduardo Sotomayor |
| title_full_unstemmed | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics edited by Jianguo Tao, Eduardo Sotomayor |
| title_short | Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics |
| title_sort | hematologic cancers from molecular pathobiology to targeted therapeutics |
| topic | Cancer Research Hematology Laboratory Medicine Molecular Medicine Apoptosis Cell Biology Cancer research Laboratory medicine Molecular biology Cell biology |
| topic_facet | Cancer Research Hematology Laboratory Medicine Molecular Medicine Apoptosis Cell Biology Cancer research Laboratory medicine Molecular biology Cell biology |
| url | https://doi.org/10.1007/978-94-007-5028-9 |
| work_keys_str_mv | AT taojianguo hematologiccancersfrommolecularpathobiologytotargetedtherapeutics AT sotomayoreduardo hematologiccancersfrommolecularpathobiologytotargetedtherapeutics |